Lv11
30 积分 2026-10-21 加入
Curcumin Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease: Mechanism Exploration, Clinical Application Strategies, and Application Limitations Challenges
25分钟前
待确认
GLP-1 receptor agonists in metabolic dysfunction–associated steatotic liver disease: mechanistic networks and translational implications: a review
56分钟前
已完结
Pan-PPAR agonists: Emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease
1小时前
已完结
皖公网安备34019202002308
